CADL R&D to Revenue
Candel Therapeutics Inc · R&D to Revenue
CADL R&D to Revenue
Latest reported0.00%period ending
CADL Quarterly R&D/Revenue (5229.03% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
CADL r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 15,148.3871% | |
| 17,341.9355% | |
| 16,200% | |
| 17,474.1935% | |
| 11,858.0645% | |
| 16,983.871% | |
| 10,619.3548% | |
| 8,880.6452% | |
| 11,400% | |
| 5,848.3871% | |
| 5,790.3226% | |
| 5,229.0323% |